These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11228361)

  • 21. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
    Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
    Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene.
    Yankauckas MA; Morrow JE; Parker SE; Abai A; Rhodes GH; Dwarki VJ; Gromkowski SH
    DNA Cell Biol; 1993 Nov; 12(9):771-6. PubMed ID: 7692877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines.
    Sullivan SM; Doukas J; Hartikka J; Smith L; Rolland A
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1433-46. PubMed ID: 21118032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity.
    Ulmer JB; Deck RR; DeWitt CM; Fu TM; Donnelly JJ; Caulfield MJ; Liu MA
    Vaccine; 1997 Jun; 15(8):839-41. PubMed ID: 9234528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines.
    Anwer K; Earle KA; Shi M; Wang J; Mumper RJ; Proctor B; Jansa K; Ledebur HC; Davis S; Eaglstein W; Rolland AP
    Pharm Res; 1999 Jun; 16(6):889-95. PubMed ID: 10397610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines.
    Rice J; King CA; Spellerberg MB; Fairweather N; Stevenson FK
    Vaccine; 1999 Aug; 17(23-24):3030-8. PubMed ID: 10462238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.
    Iwasaki A; Stiernholm BJ; Chan AK; Berinstein NL; Barber BH
    J Immunol; 1997 May; 158(10):4591-601. PubMed ID: 9144471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.
    Cui Z; Baizer L; Mumper RJ
    J Biotechnol; 2003 Apr; 102(2):105-15. PubMed ID: 12697387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antigen-specific antibody production following polyplex-based DNA vaccination via the intradermal route in mice.
    Kawase A; Isaji K; Yamaoka A; Kobayashi N; Nishikawa M; Takakura Y
    Vaccine; 2006 Jul; 24(27-28):5535-45. PubMed ID: 16716462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.
    Miura N; Shaheen SM; Akita H; Nakamura T; Harashima H
    Nucleic Acids Res; 2015 Feb; 43(3):1317-31. PubMed ID: 25605799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of humoral and cellular immune responses by antigen-expressing immunostimulatory liposomes.
    Amidi M; van Helden MJ; Tabataei NR; de Goede AL; Schouten M; de Bot V; Lanzi A; Gruters RA; Rimmelzwaan GF; Sijts AJ; Mastrobattista E
    J Control Release; 2012 Dec; 164(3):323-30. PubMed ID: 22940204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.
    Fu TM; Ulmer JB; Caulfield MJ; Deck RR; Friedman A; Wang S; Liu X; Donnelly JJ; Liu MA
    Mol Med; 1997 Jun; 3(6):362-71. PubMed ID: 9234241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses.
    Raz E; Carson DA; Parker SE; Parr TB; Abai AM; Aichinger G; Gromkowski SH; Singh M; Lew D; Yankauckas MA
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9519-23. PubMed ID: 7937799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
    McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
    Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous protection against influenza by injection of DNA encoding a viral protein.
    Ulmer JB; Donnelly JJ; Parker SE; Rhodes GH; Felgner PL; Dwarki VJ; Gromkowski SH; Deck RR; DeWitt CM; Friedman A
    Science; 1993 Mar; 259(5102):1745-9. PubMed ID: 8456302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine.
    Porter KR; Ewing D; Chen L; Wu SJ; Hayes CG; Ferrari M; Teneza-Mora N; Raviprakash K
    Vaccine; 2012 Jan; 30(2):336-41. PubMed ID: 22085548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical immunization using nanoengineered genetic vaccines.
    Cui Z; Mumper RJ
    J Control Release; 2002 May; 81(1-2):173-84. PubMed ID: 11992690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization.
    Inchauspe G; Vitvitski L; Major ME; Jung G; Spengler U; Maisonnas M; Trepo C
    DNA Cell Biol; 1997 Feb; 16(2):185-95. PubMed ID: 9052739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
    Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.